APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Drug Safety Prediction Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI Drug Safety Prediction Software Market Analysis and Forecast 2026-2032

12 August 2026171 pages

Choose your research edition.

Industry ResearchAI Drug Safety Prediction Software Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Drug Safety Prediction Software Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal AI Drug Safety Prediction Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Drug Safety Prediction Software Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Drug Safety Prediction Software Market Analysis and Forecast 2026-2032171 pages · $4,950 USD

Market perspective

The global AI Drug Safety Prediction Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI Drug Safety Prediction Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI Drug Safety Prediction Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI Drug Safety Prediction Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI Drug Safety Prediction Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI Drug Safety Prediction Software include Certara, Lhasa Limited, Instem, ACD/Labs, Chemical Computing Group, Optibrium, MultiCASE, Insilico Medicine and MindRank, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI Drug Safety Prediction Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI Drug Safety Prediction Software, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Drug Safety Prediction Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI Drug Safety Prediction Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Drug Safety Prediction Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Drug Safety Prediction Software revenue, projected growth trends, production technology, application and end-user industry.

AI Drug Safety Prediction Software Segment by Company

Certara

Lhasa Limited

Instem

ACD/Labs

Chemical Computing Group

Optibrium

MultiCASE

Insilico Medicine

MindRank

Molecular Discovery

Molecular Networks

OASIS LMC

Simulations Plus

Dassault Systèmes

Schrödinger

AI Drug Safety Prediction Software Segment by Type

Integrated ADMET Prediction

Toxicity Endpoint Prediction

Drug-Drug Interaction and PK Safety Prediction

Metabolism and Metabolite Prediction

Off-Target and Safety Pharmacology Prediction

AI Drug Safety Prediction Software Segment by Application

Hit and Lead Screening

Lead Optimization

Candidate Selection

Preclinical Safety Assessment

Regulatory Safety Assessment

Other Drug Safety Research

AI Drug Safety Prediction Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Safety Prediction Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Drug Safety Prediction Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Safety Prediction Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI Drug Safety Prediction Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI Drug Safety Prediction Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Drug Safety Prediction Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Drug Safety Prediction Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Integrated ADMET Prediction Major Player Table 3. Toxicity Endpoint Prediction Major Player Table 4. Drug-Drug Interaction and PK Safety Prediction Major Player Table 5. Metabolism and Metabolite Prediction Major Player Table 6. Off-Target and Safety Pharmacology Prediction Major Player Table 7. Global AI Drug Safety Prediction Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hit and Lead Screening Major Player Table 9. Lead Optimization Major Player Table 10. Candidate Selection Major Player Table 11. Preclinical Safety Assessment Major Player Table 12. Regulatory Safety Assessment Major Player Table 13. Other Drug Safety Research Major Player Table 14. AI Drug Safety Prediction Software Industry Trends Table 15. AI Drug Safety Prediction Software Industry Drivers Table 16. AI Drug Safety Prediction Software Industry Opportunities and Challenges Table 17. AI Drug Safety Prediction Software Industry Restraints Table 18. Global AI Drug Safety Prediction Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 19. Global AI Drug Safety Prediction Software Market Size by Region (2021-2026) & (US$ Million) Table 20. Global AI Drug Safety Prediction Software Market Share by Region (2021-2026) Table 21. Global AI Drug Safety Prediction Software Market Size by Region (2027-2032) & (US$ Million) Table 22. Global AI Drug Safety Prediction Software Market Share by Region (2027-2032) Table 23. Global AI Drug Safety Prediction Software Revenue by Players (US$ Million) & (2021-2026) Table 24. Global AI Drug Safety Prediction Software Revenue Market Share by Players (2021-2026) Table 25. Global AI Drug Safety Prediction Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 26. Global AI Drug Safety Prediction Software Key Players Headquarters & Area Served Table 27. Global AI Drug Safety Prediction Software Players, Product Type & Application Table 28. Global AI Drug Safety Prediction Software Players Establishment Date Table 29. Global Players Market Concentration Ratio (CR5 and HHI) Table 30. Global AI Drug Safety Prediction Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 31. Global AI Drug Safety Prediction Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global AI Drug Safety Prediction Software Revenue by Type (2021-2026) & (US$ Million) Table 33. Global AI Drug Safety Prediction Software Revenue by Type (2027-2032) & (US$ Million) Table 34. Global AI Drug Safety Prediction Software Revenue Market Share by Type (2021-2026) Table 35. Global AI Drug Safety Prediction Software Revenue Market Share by Type (2027-2032) Table 36. Global AI Drug Safety Prediction Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global AI Drug Safety Prediction Software Revenue by Application (2021-2026) & (US$ Million) Table 38. Global AI Drug Safety Prediction Software Revenue by Application (2027-2032) & (US$ Million) Table 39. Global AI Drug Safety Prediction Software Revenue Market Share by Application (2021-2026) Table 40. Global AI Drug Safety Prediction Software Revenue Market Share by Application (2027-2032) Table 41. Certara Company Information Table 42. Certara Business Overview Table 43. Certara AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Certara AI Drug Safety Prediction Software Product Portfolio Table 45. Certara Recent Development Table 46. Lhasa Limited Company Information Table 47. Lhasa Limited Business Overview Table 48. Lhasa Limited AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Lhasa Limited AI Drug Safety Prediction Software Product Portfolio Table 50. Lhasa Limited Recent Development Table 51. Instem Company Information Table 52. Instem Business Overview Table 53. Instem AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Instem AI Drug Safety Prediction Software Product Portfolio Table 55. Instem Recent Development Table 56. ACD/Labs Company Information Table 57. ACD/Labs Business Overview Table 58. ACD/Labs AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. ACD/Labs AI Drug Safety Prediction Software Product Portfolio Table 60. ACD/Labs Recent Development Table 61. Chemical Computing Group Company Information Table 62. Chemical Computing Group Business Overview Table 63. Chemical Computing Group AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Chemical Computing Group AI Drug Safety Prediction Software Product Portfolio Table 65. Chemical Computing Group Recent Development Table 66. Optibrium Company Information Table 67. Optibrium Business Overview Table 68. Optibrium AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Optibrium AI Drug Safety Prediction Software Product Portfolio Table 70. Optibrium Recent Development Table 71. MultiCASE Company Information Table 72. MultiCASE Business Overview Table 73. MultiCASE AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. MultiCASE AI Drug Safety Prediction Software Product Portfolio Table 75. MultiCASE Recent Development Table 76. Insilico Medicine Company Information Table 77. Insilico Medicine Business Overview Table 78. Insilico Medicine AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Insilico Medicine AI Drug Safety Prediction Software Product Portfolio Table 80. Insilico Medicine Recent Development Table 81. MindRank Company Information Table 82. MindRank Business Overview Table 83. MindRank AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. MindRank AI Drug Safety Prediction Software Product Portfolio Table 85. MindRank Recent Development Table 86. Molecular Discovery Company Information Table 87. Molecular Discovery Business Overview Table 88. Molecular Discovery AI Drug Safety Prediction Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Molecular Discovery AI Drug Safety Prediction Software Product Portfolio Table 90. Molecular Discovery Recent Development Table 91. Molecular Networks Company Information Table 92. Molecular Networks Business Overview Table 93. Molecular Networks AI Drug Safety Prediction Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Molecular Networks AI Drug Safety Prediction Software Product Portfolio Table 95. Molecular Networks Recent Development Table 96. OASIS LMC Company Information Table 97. OASIS LMC Business Overview Table 98. OASIS LMC AI Drug Safety Prediction Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. OASIS LMC AI Drug Safety Prediction Software Product Portfolio Table 100. OASIS LMC Recent Development Table 101. Simulations Plus Company Information Table 102. Simulations Plus Business Overview Table 103. Simulations Plus AI Drug Safety Prediction Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Simulations Plus AI Drug Safety Prediction Software Product Portfolio Table 105. Simulations Plus Recent Development Table 106. Dassault Systèmes Company Information Table 107. Dassault Systèmes Business Overview Table 108. Dassault Systèmes AI Drug Safety Prediction Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Dassault Systèmes AI Drug Safety Prediction Software Product Portfolio Table 110. Dassault Systèmes Recent Development Table 111. Schrödinger Company Information Table 112. Schrödinger Business Overview Table 113. Schrödinger AI Drug Safety Prediction Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Schrödinger AI Drug Safety Prediction Software Product Portfolio Table 115. Schrödinger Recent Development Table 116. North America AI Drug Safety Prediction Software Revenue by Type (2021-2026) & (US$ Million) Table 117. North America AI Drug Safety Prediction Software Revenue by Type (2027-2032) & (US$ Million) Table 118. North America AI Drug Safety Prediction Software Revenue by Application (2021-2026) & (US$ Million) Table 119. North America AI Drug Safety Prediction Software Revenue by Application (2027-2032) & (US$ Million) Table 120. North America AI Drug Safety Prediction Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America AI Drug Safety Prediction Software Revenue by Country (2021-2026) & (US$ Million) Table 122. North America AI Drug Safety Prediction Software Revenue by Country (US$ Million) & (2027-2032) Table 123. Europe AI Drug Safety Prediction Software Revenue by Type (2021-2026) & (US$ Million) Table 124. Europe AI Drug Safety Prediction Software Revenue by Type (2027-2032) & (US$ Million) Table 125. Europe AI Drug Safety Prediction Software Revenue by Application (2021-2026) & (US$ Million) Table 126. Europe AI Drug Safety Prediction Software Revenue by Application (2027-2032) & (US$ Million) Table 127. Europe AI Drug Safety Prediction Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe AI Drug Safety Prediction Software Revenue by Country (2021-2026) & (US$ Million) Table 129. Europe AI Drug Safety Prediction Software Revenue by Country (US$ Million) & (2027-2032) Table 130. China AI Drug Safety Prediction Software Revenue by Type (2021-2026) & (US$ Million) Table 131. China AI Drug Safety Prediction Software Revenue by Type (2027-2032) & (US$ Million) Table 132. China AI Drug Safety Prediction Software Revenue by Application (2021-2026) & (US$ Million) Table 133. China AI Drug Safety Prediction Software Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia AI Drug Safety Prediction Software Revenue by Type (2021-2026) & (US$ Million) Table 135. Asia AI Drug Safety Prediction Software Revenue by Type (2027-2032) & (US$ Million) Table 136. Asia AI Drug Safety Prediction Software Revenue by Application (2021-2026) & (US$ Million) Table 137. Asia AI Drug Safety Prediction Software Revenue by Application (2027-2032) & (US$ Million) Table 138. Asia AI Drug Safety Prediction Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia AI Drug Safety Prediction Software Revenue by Region (US$ Million) & (2021-2026) Table 140. Asia AI Drug Safety Prediction Software Revenue by Region (US$ Million) & (2027-2032) Table 141. SAMEA AI Drug Safety Prediction Software Revenue by Type (2021-2026) & (US$ Million) Table 142. SAMEA AI Drug Safety Prediction Software Revenue by Type (2027-2032) & (US$ Million) Table 143. SAMEA AI Drug Safety Prediction Software Revenue by Application (2021-2026) & (US$ Million) Table 144. SAMEA AI Drug Safety Prediction Software Revenue by Application (2027-2032) & (US$ Million) Table 145. SAMEA AI Drug Safety Prediction Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. SAMEA AI Drug Safety Prediction Software Revenue by Country (2021-2026) & (US$ Million) Table 147. SAMEA AI Drug Safety Prediction Software Revenue by Country (US$ Million) & (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. AI Drug Safety Prediction Software Image Figure 2. Global AI Drug Safety Prediction Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Drug Safety Prediction Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Integrated ADMET Prediction Image Figure 5. Toxicity Endpoint Prediction Image Figure 6. Drug-Drug Interaction and PK Safety Prediction Image Figure 7. Metabolism and Metabolite Prediction Image Figure 8. Off-Target and Safety Pharmacology Prediction Image Figure 9. Global AI Drug Safety Prediction Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global AI Drug Safety Prediction Software Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hit and Lead Screening Image Figure 12. Lead Optimization Image Figure 13. Candidate Selection Image Figure 14. Preclinical Safety Assessment Image Figure 15. Regulatory Safety Assessment Image Figure 16. Other Drug Safety Research Image Figure 17. Global AI Drug Safety Prediction Software Market Size (US$ Million) & (2021-2032) Figure 18. Global AI Drug Safety Prediction Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global AI Drug Safety Prediction Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 20. Global AI Drug Safety Prediction Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global AI Drug Safety Prediction Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global AI Drug Safety Prediction Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global AI Drug Safety Prediction Software Revenue Market Share by Type (2021-2032) Figure 25. Global AI Drug Safety Prediction Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global AI Drug Safety Prediction Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 27. Global AI Drug Safety Prediction Software Revenue Market Share by Application (2021-2032) Figure 28. North America AI Drug Safety Prediction Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. North America AI Drug Safety Prediction Software Revenue Share by Type (2021-2032) Figure 30. North America AI Drug Safety Prediction Software Revenue Share by Application (2021-2032) Figure 31. North America AI Drug Safety Prediction Software Revenue Share by Country (2021-2032) Figure 32. United States AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Canada AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Mexico AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Europe AI Drug Safety Prediction Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 36. Europe AI Drug Safety Prediction Software Revenue Share by Type (2021-2032) Figure 37. Europe AI Drug Safety Prediction Software Revenue Share by Application (2021-2032) Figure 38. Europe AI Drug Safety Prediction Software Revenue Share by Country (2021-2032) Figure 39. Germany AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. France AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. U.K. AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Italy AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Spain AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Russia AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Netherlands AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Nordic Countries AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. China AI Drug Safety Prediction Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. China AI Drug Safety Prediction Software Revenue Share by Type (2021-2032) Figure 49. China AI Drug Safety Prediction Software Revenue Share by Application (2021-2032) Figure 50. Asia AI Drug Safety Prediction Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 51. Asia AI Drug Safety Prediction Software Revenue Share by Type (2021-2032) Figure 52. Asia AI Drug Safety Prediction Software Revenue Share by Application (2021-2032) Figure 53. Asia AI Drug Safety Prediction Software Revenue Share by Region (2021-2032) Figure 54. Japan AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. South Korea AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. India AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Australia AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Taiwan AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Southeast Asia AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. SAMEA AI Drug Safety Prediction Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 61. SAMEA AI Drug Safety Prediction Software Revenue Share by Type (2021-2032) Figure 62. SAMEA AI Drug Safety Prediction Software Revenue Share by Application (2021-2032) Figure 63. SAMEA AI Drug Safety Prediction Software Revenue Share by Country (2021-2032) Figure 64. Brazil AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Argentina AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Chile AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Colombia AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Peru AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Saudi Arabia AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Israel AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. UAE AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Turkey AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Iran AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Egypt AI Drug Safety Prediction Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Integrated ADMET Prediction
  • Toxicity Endpoint Prediction
  • Drug-Drug Interaction and PK Safety Prediction
  • Metabolism and Metabolite Prediction
  • Off-Target and Safety Pharmacology Prediction
Applications
  • Hit and Lead Screening
  • Lead Optimization
  • Candidate Selection
  • Preclinical Safety Assessment
  • Regulatory Safety Assessment
  • Other Drug Safety Research
Companies covered
  • Certara
  • Lhasa Limited
  • Instem
  • ACD/Labs
  • Chemical Computing Group
  • Optibrium
  • MultiCASE
  • Insilico Medicine
  • MindRank
  • Molecular Discovery
  • Molecular Networks
  • OASIS LMC
  • Simulations Plus
  • Dassault Systèmes
  • Schrödinger

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI Drug Safety Prediction Software Market by Type
  3. 1.2.1 Global AI Drug Safety Prediction Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Integrated ADMET Prediction
  5. 1.2.3 Toxicity Endpoint Prediction
  6. 1.2.4 Drug-Drug Interaction and PK Safety Prediction
  7. 1.2.5 Metabolism and Metabolite Prediction
  8. 1.2.6 Off-Target and Safety Pharmacology Prediction
  9. 1.3 AI Drug Safety Prediction Software Market by Application
  10. 1.3.1 Global AI Drug Safety Prediction Software Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hit and Lead Screening
  12. 1.3.3 Lead Optimization
  13. 1.3.4 Candidate Selection
  14. 1.3.5 Preclinical Safety Assessment
  15. 1.3.6 Regulatory Safety Assessment
  16. 1.3.7 Other Drug Safety Research
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 AI Drug Safety Prediction Software Market Dynamics
  1. 2.1 AI Drug Safety Prediction Software Industry Trends
  2. 2.2 AI Drug Safety Prediction Software Industry Drivers
  3. 2.3 AI Drug Safety Prediction Software Industry Opportunities and Challenges
  4. 2.4 AI Drug Safety Prediction Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI Drug Safety Prediction Software Market Perspective (2021-2032)
  2. 3.2 Global AI Drug Safety Prediction Software Growth Trends by Region
  3. 3.2.1 Global AI Drug Safety Prediction Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI Drug Safety Prediction Software Market Size by Region (2021-2026)
  5. 3.2.3 Global AI Drug Safety Prediction Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI Drug Safety Prediction Software Revenue by Players
  2. 4.1.1 Global AI Drug Safety Prediction Software Revenue by Players (2021-2026)
  3. 4.1.2 Global AI Drug Safety Prediction Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI Drug Safety Prediction Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI Drug Safety Prediction Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI Drug Safety Prediction Software Key Players Headquarters & Area Served
  7. 4.4 Global AI Drug Safety Prediction Software Players, Product Type & Application
  8. 4.5 Global AI Drug Safety Prediction Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI Drug Safety Prediction Software Market CR5 and HHI
  11. 4.6.3 2025 AI Drug Safety Prediction Software Tier 1, Tier 2, and Tier 3
5 AI Drug Safety Prediction Software Market Size by Type
  1. 5.1 Global AI Drug Safety Prediction Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Drug Safety Prediction Software Revenue by Type (2021-2032)
  3. 5.3 Global AI Drug Safety Prediction Software Revenue Market Share by Type (2021-2032)
6 AI Drug Safety Prediction Software Market Size by Application
  1. 6.1 Global AI Drug Safety Prediction Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI Drug Safety Prediction Software Revenue by Application (2021-2032)
  3. 6.3 Global AI Drug Safety Prediction Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Certara
  2. 7.1.1 Certara Company Information
  3. 7.1.2 Certara Business Overview
  4. 7.1.3 Certara AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Certara AI Drug Safety Prediction Software Product Portfolio
  6. 7.1.5 Certara Recent Developments
  7. 7.2 Lhasa Limited
  8. 7.2.1 Lhasa Limited Company Information
  9. 7.2.2 Lhasa Limited Business Overview
  10. 7.2.3 Lhasa Limited AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Lhasa Limited AI Drug Safety Prediction Software Product Portfolio
  12. 7.2.5 Lhasa Limited Recent Developments
  13. 7.3 Instem
  14. 7.3.1 Instem Company Information
  15. 7.3.2 Instem Business Overview
  16. 7.3.3 Instem AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Instem AI Drug Safety Prediction Software Product Portfolio
  18. 7.3.5 Instem Recent Developments
  19. 7.4 ACD/Labs
  20. 7.4.1 ACD/Labs Company Information
  21. 7.4.2 ACD/Labs Business Overview
  22. 7.4.3 ACD/Labs AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 ACD/Labs AI Drug Safety Prediction Software Product Portfolio
  24. 7.4.5 ACD/Labs Recent Developments
  25. 7.5 Chemical Computing Group
  26. 7.5.1 Chemical Computing Group Company Information
  27. 7.5.2 Chemical Computing Group Business Overview
  28. 7.5.3 Chemical Computing Group AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Chemical Computing Group AI Drug Safety Prediction Software Product Portfolio
  30. 7.5.5 Chemical Computing Group Recent Developments
  31. 7.6 Optibrium
  32. 7.6.1 Optibrium Company Information
  33. 7.6.2 Optibrium Business Overview
  34. 7.6.3 Optibrium AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Optibrium AI Drug Safety Prediction Software Product Portfolio
  36. 7.6.5 Optibrium Recent Developments
  37. 7.7 MultiCASE
  38. 7.7.1 MultiCASE Company Information
  39. 7.7.2 MultiCASE Business Overview
  40. 7.7.3 MultiCASE AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 MultiCASE AI Drug Safety Prediction Software Product Portfolio
  42. 7.7.5 MultiCASE Recent Developments
  43. 7.8 Insilico Medicine
  44. 7.8.1 Insilico Medicine Company Information
  45. 7.8.2 Insilico Medicine Business Overview
  46. 7.8.3 Insilico Medicine AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Insilico Medicine AI Drug Safety Prediction Software Product Portfolio
  48. 7.8.5 Insilico Medicine Recent Developments
  49. 7.9 MindRank
  50. 7.9.1 MindRank Company Information
  51. 7.9.2 MindRank Business Overview
  52. 7.9.3 MindRank AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 MindRank AI Drug Safety Prediction Software Product Portfolio
  54. 7.9.5 MindRank Recent Developments
  55. 7.10 Molecular Discovery
  56. 7.10.1 Molecular Discovery Company Information
  57. 7.10.2 Molecular Discovery Business Overview
  58. 7.10.3 Molecular Discovery AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Molecular Discovery AI Drug Safety Prediction Software Product Portfolio
  60. 7.10.5 Molecular Discovery Recent Developments
  61. 7.11 Molecular Networks
  62. 7.11.1 Molecular Networks Company Information
  63. 7.11.2 Molecular Networks Business Overview
  64. 7.11.3 Molecular Networks AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Molecular Networks AI Drug Safety Prediction Software Product Portfolio
  66. 7.11.5 Molecular Networks Recent Developments
  67. 7.12 OASIS LMC
  68. 7.12.1 OASIS LMC Company Information
  69. 7.12.2 OASIS LMC Business Overview
  70. 7.12.3 OASIS LMC AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 OASIS LMC AI Drug Safety Prediction Software Product Portfolio
  72. 7.12.5 OASIS LMC Recent Developments
  73. 7.13 Simulations Plus
  74. 7.13.1 Simulations Plus Company Information
  75. 7.13.2 Simulations Plus Business Overview
  76. 7.13.3 Simulations Plus AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Simulations Plus AI Drug Safety Prediction Software Product Portfolio
  78. 7.13.5 Simulations Plus Recent Developments
  79. 7.14 Dassault Systèmes
  80. 7.14.1 Dassault Systèmes Company Information
  81. 7.14.2 Dassault Systèmes Business Overview
  82. 7.14.3 Dassault Systèmes AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Dassault Systèmes AI Drug Safety Prediction Software Product Portfolio
  84. 7.14.5 Dassault Systèmes Recent Developments
  85. 7.15 Schrödinger
  86. 7.15.1 Schrödinger Company Information
  87. 7.15.2 Schrödinger Business Overview
  88. 7.15.3 Schrödinger AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Schrödinger AI Drug Safety Prediction Software Product Portfolio
  90. 7.15.5 Schrödinger Recent Developments
8 North America
  1. 8.1 North America AI Drug Safety Prediction Software Revenue (2021-2032)
  2. 8.2 North America AI Drug Safety Prediction Software Revenue by Type (2021-2032)
  3. 8.2.1 North America AI Drug Safety Prediction Software Revenue by Type (2021-2026)
  4. 8.2.2 North America AI Drug Safety Prediction Software Revenue by Type (2027-2032)
  5. 8.3 North America AI Drug Safety Prediction Software Revenue Share by Type (2021-2032)
  6. 8.4 North America AI Drug Safety Prediction Software Revenue by Application (2021-2032)
  7. 8.4.1 North America AI Drug Safety Prediction Software Revenue by Application (2021-2026)
  8. 8.4.2 North America AI Drug Safety Prediction Software Revenue by Application (2027-2032)
  9. 8.5 North America AI Drug Safety Prediction Software Revenue Share by Application (2021-2032)
  10. 8.6 North America AI Drug Safety Prediction Software Revenue by Country
  11. 8.6.1 North America AI Drug Safety Prediction Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI Drug Safety Prediction Software Revenue by Country (2021-2026)
  13. 8.6.3 North America AI Drug Safety Prediction Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI Drug Safety Prediction Software Revenue (2021-2032)
  2. 9.2 Europe AI Drug Safety Prediction Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI Drug Safety Prediction Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI Drug Safety Prediction Software Revenue by Type (2027-2032)
  5. 9.3 Europe AI Drug Safety Prediction Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI Drug Safety Prediction Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI Drug Safety Prediction Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI Drug Safety Prediction Software Revenue by Application (2027-2032)
  9. 9.5 Europe AI Drug Safety Prediction Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI Drug Safety Prediction Software Revenue by Country
  11. 9.6.1 Europe AI Drug Safety Prediction Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI Drug Safety Prediction Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI Drug Safety Prediction Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI Drug Safety Prediction Software Revenue (2021-2032)
  2. 10.2 China AI Drug Safety Prediction Software Revenue by Type (2021-2032)
  3. 10.2.1 China AI Drug Safety Prediction Software Revenue by Type (2021-2026)
  4. 10.2.2 China AI Drug Safety Prediction Software Revenue by Type (2027-2032)
  5. 10.3 China AI Drug Safety Prediction Software Revenue Share by Type (2021-2032)
  6. 10.4 China AI Drug Safety Prediction Software Revenue by Application (2021-2032)
  7. 10.4.1 China AI Drug Safety Prediction Software Revenue by Application (2021-2026)
  8. 10.4.2 China AI Drug Safety Prediction Software Revenue by Application (2027-2032)
  9. 10.5 China AI Drug Safety Prediction Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI Drug Safety Prediction Software Revenue (2021-2032)
  2. 11.2 Asia AI Drug Safety Prediction Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI Drug Safety Prediction Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI Drug Safety Prediction Software Revenue by Type (2027-2032)
  5. 11.3 Asia AI Drug Safety Prediction Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI Drug Safety Prediction Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI Drug Safety Prediction Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI Drug Safety Prediction Software Revenue by Application (2027-2032)
  9. 11.5 Asia AI Drug Safety Prediction Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI Drug Safety Prediction Software Revenue by Country
  11. 11.6.1 Asia AI Drug Safety Prediction Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI Drug Safety Prediction Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI Drug Safety Prediction Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI Drug Safety Prediction Software Revenue (2021-2032)
  2. 12.2 SAMEA AI Drug Safety Prediction Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI Drug Safety Prediction Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI Drug Safety Prediction Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI Drug Safety Prediction Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI Drug Safety Prediction Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI Drug Safety Prediction Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI Drug Safety Prediction Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI Drug Safety Prediction Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI Drug Safety Prediction Software Revenue by Country
  11. 12.6.1 SAMEA AI Drug Safety Prediction Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI Drug Safety Prediction Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI Drug Safety Prediction Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst